A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Conditions:   Advanced Solid Tumor;   Refractory Tumor Interventions:   Radiation: Radiotherapy;   Drug: PD-1/PD-L1 inhibitor;   Drug: Granulocyte-macrophage colony-stimulating factor subcutaneous injection;   Drug: Interleukin 2 subcutaneous injection;   Drug: Endostatin Sponsor:   Second Affiliated Hospital of Soochow University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials